IkB-alpha Antibody (6A920) - BSA Free

Novus Biologicals | Catalog # NB100-56507

Novus Biologicals
Loading...

Key Product Details

Validated by

Knockout/Knockdown, Biological Validation

Species Reactivity

Validated:

Human, Mouse, Rat

Cited:

Human, Mouse, Rat

Applications

Validated:

Knockout Validated, Immunohistochemistry, Immunohistochemistry-Paraffin, Western Blot, Flow Cytometry, Immunocytochemistry/ Immunofluorescence, Simple Western, Immunoprecipitation, CyTOF-ready

Cited:

Immunohistochemistry-Paraffin, Western Blot, Immunocytochemistry/ Immunofluorescence, Simple Western, Immunoprecipitation

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG1 kappa Clone # 6A920

Format

BSA Free
Loading...

Product Specifications

Immunogen

Partial recombinant protein corresponding to amino acid residues 32-291 of human IkB-alpha.

Reactivity Notes

Rat reactivity reported in the scientific literature (PMID: 23840265).

Clonality

Monoclonal

Host

Mouse

Isotype

IgG1 kappa

Scientific Data Images for IkB-alpha Antibody (6A920) - BSA Free

Knockout Validated: IkB-alpha Antibody (6A920) - BSA Free [NB100-56507]

Western Blot: IkB-alpha Antibody (6A920) - BSA Free [NB100-56507]

Western Blot: IkB-alpha Antibody (6A920) [NB100-56507] - Western blot shows lysates of HEK293 human embryonic kidney parental cell line and IkB-alpha knockout (KO) HEK293 human embryonic kidney cell line. PVDF membrane was probed with 2 ug/ml of Mouse Anti-Human IkB-alpha monoclonal Antibody (Catalog # NB100-56507) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody. Specific band was detected for IkB-alpha at approximately 38 kDa (as indicated) in the parental HEK293 celll line, but is not detectable in the knockout HEK293 cell line. This experiment was conducted under reducing conditions.
Western Blot: IkB-alpha Antibody (6A920)BSA Free [NB100-56507]

Western Blot: IkB-alpha Antibody (6A920)BSA Free [NB100-56507]

Western Blot: IkB-alpha Antibody (6A920) [NB100-56507] - Lysates of Jurkat human acute T cell leukemia cell line, LNCaP human prostate cancer cell line, PCx2011;3 human prostate cancer cell line, HeLa human cervical epithelial carcinoma cell line, and NIHx2011;3T3 mouse embryonic fibroblast cell line. PVDF membrane was probed with 0.5 ug/mL mouse anti-IkB-a monoclonal (NB100-56507, Novus Biologicals), followed by 1:2000 dilution of the appropriate HRP-conjugated secondary antibody, donkey anti-mouse IgG.
Immunocytochemistry/ Immunofluorescence: IkB-alpha Antibody (6A920) - BSA Free [NB100-56507]

Immunocytochemistry/ Immunofluorescence: IkB-alpha Antibody (6A920) - BSA Free [NB100-56507]

Immunocytochemistry/Immunofluorescence: IkB-alpha Antibody (6A920) [NB100-56507] - Hek293 cells were fixed for 10 minutes using 10% formalin and then permeabilized for 5 minutes using 1X PBS + 0.05% Triton-X100. The cells were incubated with anti-IkB-alpha (6A920) at 2 ug/ml overnight at 4C and detected with an anti-mouse Dylight 488 (Green) at a 1:500 dilution. Actin was detected with Phalloidin 568 (Red) at a 1:200 dilution. Nuclei were counterstained with DAPI (Blue). Cells were imaged using a 40X objective.
Immunohistochemistry-Paraffin: IkB-alpha Antibody (6A920) - BSA Free [NB100-56507]

Immunohistochemistry-Paraffin: IkB-alpha Antibody (6A920) - BSA Free [NB100-56507]

Immunohistochemistry-Paraffin: IkB-alpha Antibody (6A920) [NB100-56507] - Analysis of a FFPE tissue section of human breast using 1:200 dilution of IkB-alpha clone 6A920 antibody. The staining was developed using HRP labeled anti-rabbit secondary antibody and DAB reagent, and nuclei of cells were counter-stained with hematoxylin. Cytoplasmic and membrane staining of glandular cells was observed.
Flow Cytometry: IkB-alpha Antibody (6A920) - BSA Free [NB100-56507]

Flow Cytometry: IkB-alpha Antibody (6A920) - BSA Free [NB100-56507]

Flow Cytometry: IkB-alpha Antibody (6A920) [NB100-56507] - An intracellular stain was performed on NIH3T3 cells with IkB-alpha Antibody [6A920] NB100-56507 (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 1.0 ug/mL for 30 minutes at room temperature, followed by Mouse IgG (H+L) Cross-Adsorbed Secondary Antibody, Dylight 550.
Western Blot: IkB-alpha Antibody (6A920)BSA Free [NB100-56507]

Western Blot: IkB-alpha Antibody (6A920)BSA Free [NB100-56507]

Western Blot: IkB-alpha Antibody (6A920) [NB100-56507] - IkBa using NB100-56507 at 2 ug/ml in (A) Daudi and (B) NIH 3T3 whole cell lysate.
Western Blot: IkB-alpha Antibody (6A920)BSA Free [NB100-56507]

Western Blot: IkB-alpha Antibody (6A920)BSA Free [NB100-56507]

Western Blot: IkB-alpha Antibody (6A920) [NB100-56507] - Jurkat cells were treated for 30 min with 100 ug/ml ALLN (N-Acetyl-Leu-Leu-Norleucinal; a Calpain inhibitor and also proteasome inhibitor that prevents IkBa dephosphorylation) followed by incubation with (lanes 2 & 4) or without 1 nM TNF-a (1 & 3). The membranes were blotted with NB100-56724 (lanes 1 & 2) or NB100-56507 (that recognizes both non-phospho and phosphorylated forms of IkBa) and immunoreactivity was detected by ECL. The data shows that NB100-56724 detects specifically the phosphorylated form of IkBa.
Flow Cytometry: IkB-alpha Antibody (6A920) - BSA Free [NB100-56507]

Flow Cytometry: IkB-alpha Antibody (6A920) - BSA Free [NB100-56507]

Flow Cytometry: IkB-alpha Antibody (6A920) [NB100-56507] - Intracellular staining of 10^6 ThP-1 cells using 0.25 ug of NB100-56507. Shaded histogram represents cells alone, green represents the isotype control, and red represents the IkBa antibody. Novus's intracellular flow kit was used for this test, and an anti-mouse IgG FITC conjugated secondary.
Flow Cytometry: IkB-alpha Antibody (6A920) - BSA Free [NB100-56507]

Flow Cytometry: IkB-alpha Antibody (6A920) - BSA Free [NB100-56507]

Flow Cytometry: IkB-alpha Antibody (6A920) [NB100-56507] - An intracellular stain was performed on Hek293 cells with IkB-alpha Antibody [6A920] NB100-56507 (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 1.0 ug/mL for 30 minutes at room temperature, followed by Mouse IgG (H+L) Cross-Adsorbed Secondary Antibody, Dylight 550.
Simple Western: IkB-alpha Antibody (6A920)BSA Free [NB100-56507]

Simple Western: IkB-alpha Antibody (6A920)BSA Free [NB100-56507]

Simple Western: IkB-alpha Antibody (6A920) [NB100-56507] - Simple Western lane view shows a specific band for IKB alpha in 0.5 mg/ml of NIH-3T3 lysate. This experiment was performed under reducing conditions using the 12-230 kDa separation system.
IkB-alpha Antibody (6A920) - BSA Free

IkB-alpha Antibody (6A920) in HepG2 Human Cell Line.

IkB-alpha Antibody (6A920) was detected in immersion fixed HepG2 human hepatocellular carcinoma cell line using Mouse anti-IkB-alpha Antibody (6A920) Protein G Purified Monoclonal Antibody conjugated to FITC (Catalog # NB100-56507F) (green) at 10 µg/mL overnight at 4C. Cells were counterstained with DAPI (blue). Cells were imaged using a 100X objective and digitally deconvolved.
IkB-alpha Antibody (6A920) - BSA Free

Western Blot: IkB-alpha Antibody (6A920) - BSA Free [NB100-56507] -

NGF-NGFR restricts the TNF/NF-kappa B signaling.a NGFR deletion enhanced TNF-induced phosphorylation of p65. v, empty vector; 2–8, different sgRNAs targeting Ngfr. n = 3 independent experiments. b NGF reduced TNF-induced p-p65, which required NGFR. v vehicle. T, TNF. N, NGF. T + N, TNF + NGF. Cells were treated with indicated growth factor/cytokine for 15 min. sgRNA #2 was used to generate NGFR KO. n = 3 independent experiments. c NGFR overexpression reduced p-p65 and p-I kappa B alpha in C2C12 cells treated with TNF for 24 h. R, RFP. N, hNGFR-RFP. n = 3 independent experiments. d NGFR overexpression decreased p-p65 and p-I kappa B alpha induced by TNF treatment in non-skeletal HEK293 cells. n = 3 independent experiments. e NGF treatment decreased NF-kappa B activation induced by TNF in HEK293 cells. n = 3 independent experiments. Source data are provided as a Source Data file. Image collected and cropped by CiteAb from the following open publication (https://www.nature.com/articles/s41467-024-47633-6), licensed under a CC-BY license. Not internally tested by Novus Biologicals.
IkB-alpha Antibody (6A920) - BSA Free

Western Blot: IkB-alpha Antibody (6A920) - BSA Free [NB100-56507] -

NGF-NGFR restricts the TNF/NF-kappa B signaling.a NGFR deletion enhanced TNF-induced phosphorylation of p65. v, empty vector; 2–8, different sgRNAs targeting Ngfr. n = 3 independent experiments. b NGF reduced TNF-induced p-p65, which required NGFR. v vehicle. T, TNF. N, NGF. T + N, TNF + NGF. Cells were treated with indicated growth factor/cytokine for 15 min. sgRNA #2 was used to generate NGFR KO. n = 3 independent experiments. c NGFR overexpression reduced p-p65 and p-I kappa B alpha in C2C12 cells treated with TNF for 24 h. R, RFP. N, hNGFR-RFP. n = 3 independent experiments. d NGFR overexpression decreased p-p65 and p-I kappa B alpha induced by TNF treatment in non-skeletal HEK293 cells. n = 3 independent experiments. e NGF treatment decreased NF-kappa B activation induced by TNF in HEK293 cells. n = 3 independent experiments. Source data are provided as a Source Data file. Image collected and cropped by CiteAb from the following open publication (https://www.nature.com/articles/s41467-024-47633-6), licensed under a CC-BY license. Not internally tested by Novus Biologicals.
IkB-alpha Antibody (6A920) - BSA Free

Western Blot: IkB-alpha Antibody (6A920) - BSA Free [NB100-56507] -

NGF-NGFR restricts the TNF/NF-kappa B signaling.a NGFR deletion enhanced TNF-induced phosphorylation of p65. v, empty vector; 2–8, different sgRNAs targeting Ngfr. n = 3 independent experiments. b NGF reduced TNF-induced p-p65, which required NGFR. v vehicle. T, TNF. N, NGF. T + N, TNF + NGF. Cells were treated with indicated growth factor/cytokine for 15 min. sgRNA #2 was used to generate NGFR KO. n = 3 independent experiments. c NGFR overexpression reduced p-p65 and p-I kappa B alpha in C2C12 cells treated with TNF for 24 h. R, RFP. N, hNGFR-RFP. n = 3 independent experiments. d NGFR overexpression decreased p-p65 and p-I kappa B alpha induced by TNF treatment in non-skeletal HEK293 cells. n = 3 independent experiments. e NGF treatment decreased NF-kappa B activation induced by TNF in HEK293 cells. n = 3 independent experiments. Source data are provided as a Source Data file. Image collected and cropped by CiteAb from the following open publication (https://www.nature.com/articles/s41467-024-47633-6), licensed under a CC-BY license. Not internally tested by Novus Biologicals.
IkB-alpha Antibody (6A920) - BSA Free

Western Blot: IkB-alpha Antibody (6A920) - BSA Free [NB100-56507] -

NGF-NGFR restricts the TNF/NF-kappa B signaling.a NGFR deletion enhanced TNF-induced phosphorylation of p65. v, empty vector; 2–8, different sgRNAs targeting Ngfr. n = 3 independent experiments. b NGF reduced TNF-induced p-p65, which required NGFR. v vehicle. T, TNF. N, NGF. T + N, TNF + NGF. Cells were treated with indicated growth factor/cytokine for 15 min. sgRNA #2 was used to generate NGFR KO. n = 3 independent experiments. c NGFR overexpression reduced p-p65 and p-I kappa B alpha in C2C12 cells treated with TNF for 24 h. R, RFP. N, hNGFR-RFP. n = 3 independent experiments. d NGFR overexpression decreased p-p65 and p-I kappa B alpha induced by TNF treatment in non-skeletal HEK293 cells. n = 3 independent experiments. e NGF treatment decreased NF-kappa B activation induced by TNF in HEK293 cells. n = 3 independent experiments. Source data are provided as a Source Data file. Image collected and cropped by CiteAb from the following open publication (https://www.nature.com/articles/s41467-024-47633-6), licensed under a CC-BY license. Not internally tested by Novus Biologicals.
IkB-alpha Antibody (6A920) - BSA Free

Western Blot: IkB-alpha Antibody (6A920) - BSA Free [NB100-56507] -

NGF-NGFR restricts the TNF/NF-kappa B signaling.a NGFR deletion enhanced TNF-induced phosphorylation of p65. v, empty vector; 2–8, different sgRNAs targeting Ngfr. n = 3 independent experiments. b NGF reduced TNF-induced p-p65, which required NGFR. v vehicle. T, TNF. N, NGF. T + N, TNF + NGF. Cells were treated with indicated growth factor/cytokine for 15 min. sgRNA #2 was used to generate NGFR KO. n = 3 independent experiments. c NGFR overexpression reduced p-p65 and p-I kappa B alpha in C2C12 cells treated with TNF for 24 h. R, RFP. N, hNGFR-RFP. n = 3 independent experiments. d NGFR overexpression decreased p-p65 and p-I kappa B alpha induced by TNF treatment in non-skeletal HEK293 cells. n = 3 independent experiments. e NGF treatment decreased NF-kappa B activation induced by TNF in HEK293 cells. n = 3 independent experiments. Source data are provided as a Source Data file. Image collected and cropped by CiteAb from the following open publication (https://www.nature.com/articles/s41467-024-47633-6), licensed under a CC-BY license. Not internally tested by Novus Biologicals.

Applications for IkB-alpha Antibody (6A920) - BSA Free

Application
Recommended Usage

Flow Cytometry

0.25-1 ug/10^6 cells

Immunocytochemistry/ Immunofluorescence

1:100-1:1000

Immunohistochemistry

1:20-1:1000

Immunohistochemistry-Paraffin

1:100

Immunoprecipitation

1 ug/ml

Simple Western

1:20

Western Blot

1-2 ug/ml
Application Notes
A 40 kDa band is observed.

Flow Cytometry Panel Builder

Bio-Techne Knows Flow Cytometry

Save time and reduce costly mistakes by quickly finding compatible reagents using the Panel Builder Tool.

Advanced Features

  • Spectra Viewer - Custom analysis of spectra from multiple fluorochromes
  • Spillover Popups - Visualize the spectra of individual fluorochromes
  • Antigen Density Selector - Match fluorochrome brightness with antigen density
Build Your Panel Now

Formulation, Preparation, and Storage

Purification

Protein G purified

Formulation

PBS

Format

BSA Free

Preservative

0.02% Sodium Azide

Concentration

1.0 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: IkB-alpha

IkBa Inhibits the activity of dimeric NF-kappa-B/REL complexes by trapping REL dimers in the cytoplasm through masking of their nuclear localization signals. On cellular stimulation by immune and proinflammatory responses IkBa becomes phosphorylated, promoting ubiquitination and degradation, enabling the dimeric RELA to translocate to the nucleus and activate transcription. IkB proteins are phosphorylated by IkB kinase complex consisting of at least three proteins, IKK1/a, IKK2/b, and IKK3/g.

Long Name

I-kappa-B-alpha

Alternate Names

IkBalpha, MAD-3, NFKBIA

Entrez Gene IDs

4792 (Human); 18035 (Mouse)

Gene Symbol

NFKBIA

UniProt

Additional IkB-alpha Products

Product Documents for IkB-alpha Antibody (6A920) - BSA Free

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Product Specific Notices for IkB-alpha Antibody (6A920) - BSA Free

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Citations for IkB-alpha Antibody (6A920) - BSA Free

Customer Reviews for IkB-alpha Antibody (6A920) - BSA Free

There are currently no reviews for this product. Be the first to review IkB-alpha Antibody (6A920) - BSA Free and earn rewards!

Have you used IkB-alpha Antibody (6A920) - BSA Free?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for IkB-alpha Antibody (6A920) - BSA Free (NB100-56507):

Protocol for Flow Cytometry Intracellular Staining
Sample Preparation.
1. Grow cells to 60-85% confluency. Flow cytometry requires between 2 x 105 and 1 x 106 cells for optimal performance.
2. If cells are adherent, harvest gently by washing once with staining buffer and then scraping. Avoid using trypsin as this can disrupt certain epitopes of interest. If enzymatic harvest is required, use Accutase, Collagenase, or TrypLE Express for a less damaging option.
3. Reserve 100 uL for counting, then transfer cell volume into a 50 mL conical tube and centrifuge for 8 minutes at 400 RCF.
a. Count cells using a hemocytometer and a 1:1 trypan blue exclusion stain to determine cell viability before starting the flow protocol. If cells appear blue, do not proceed.
4. Re-suspend cells to a concentration of 1 x 106 cells/mL in staining buffer (NBP2-26247).
5. Aliquot out 100 uL samples in accordance with your experimental samples.

Tip: When cell surface and intracellular staining are required in the same sample, it is advisable that the cell surface staining be performed first since the fixation and permeablization steps might reduce the availability of surface antigens.

Intracellular Staining.
Tip: When performing intracellular staining, it is important to use appropriate fixation and permeabilization reagents based upon the target and its subcellular location. Generally, our Intracellular Flow Assay Kit (NBP2-29450) is a good place to start as it contains an optimized combination of reagents for intracellular staining as well as an inhibitor of intracellular protein transport (necessary if staining secreted proteins). Certain targets may require more gentle or transient permeabilization protocols such as the commonly employed methanol or saponin-based methods.
Protocol for Cytoplasmic Targets:
1. Fix the cells by adding 100 uL fixation solution (such as 4% PFA) to each sample for 10-15 minutes.
2. Permeabilize cells by adding 100 uL of a permeabization buffer to every 1 x 106 cells present in the sample. Mix well and incubate at room temperature for 15 minutes.
a. For cytoplasmic targets, use a gentle permeabilization solution such as 1X PBS + 0.5% Saponin or 1X PBS + 0.5% Tween-20.
b. To maintain the permeabilized state throughout your experiment, use staining buffer + 0.1% of the permeabilization reagent (i.e. 0.1% Tween-20 or 0.1% Saponin).
3. Following the 15 minute incubation, add 2 mL of the staining buffer + 0.1% permeabilizer to each sample.
4. Centrifuge for 1 minute at 400 RCF.
5. Discard supernatant and re-suspend in 100 uL of staining buffer + 0.1% permeabilizer.
6. Add appropriate amount of each antibody (eg. 1 test or 1 ug per sample, as experimentally determined).
7. Mix well and incubate at room temperature for 30 minutes- 1 hour. Gently mix samples every 10-15 minutes.
8. Following the primary/conjugate incubation, add 1-2 mL/sample of staining buffer +0.1% permeabilizer and centrifuge for 1 minute at 400 RCF.
9. Wash twice by re-suspending cells in staining buffer (2 mL for tubes or 200 uL for wells) and centrifuging at 400 RCF for 5 minutes. Discard supernatant.
10. Add appropriate amount of secondary antibody (as experimentally determined) to each sample.
11. Incubate at room temperature in dark for 20 minutes.
12. Add 1-2 mL of staining buffer and centrifuge at 400 RCF for 1 minute and discard supernatant.
13. Wash twice by re-suspending cells in staining buffer (2 mL for tubes or 200 uL for wells) and centrifuging at 400 RCF for 5 minutes. Discard supernatant.
14. Resuspend in an appropriate volume of staining buffer (usually 500 uL per sample) and proceed with analysis on your flow cytometer.

Immunocytochemistry Protocol

Culture cells to appropriate density in 35 mm culture dishes or 6-well plates.

1. Remove culture medium and wash the cells briefly in PBS. Add 10% formalin to the dish and fix at room temperature for 10 minutes.
2. Remove the formalin and wash the cells in PBS.
3. Permeablize the cells with 0.1% Triton X100 or other suitable detergent for 10 min.
4. Remove the permeablization buffer and wash three times for 10 minutes each in PBS. Be sure to not let the specimen dry out.
5. To block nonspecific antibody binding, incubate in 10% normal goat serum from 1 hour to overnight at room temperature.
6. Add primary antibody at appropriate dilution and incubate overnight at 4C.
7. Remove primary antibody and replace with PBS. Wash three times for 10 minutes each.
8. Add secondary antibody at appropriate dilution. Incubate for 1 hour at room temperature.
9. Remove secondary antibody and replace with PBS. Wash three times for 10 minutes each.
10. Counter stain DNA with DAPi if required.

Immunohistochemistry-Paraffin Embedded Sections

Antigen Unmasking:
Bring slides to a boil in 10 mM sodium citrate buffer (pH 6.0) then maintain at a sub-boiling temperature for 10 minutes. Cool slides on bench-top for 30 minutes (keep slides in the sodium citrate buffer all the time).

Staining:
1. Wash sections in deionized water three times for 5 minutes each.
2. Wash sections in PBS for 5 minutes.
3. Block each section with 100-400 ul blocking solution (1% BSA in PBS) for 1 hour at room temperature.
4. Remove blocking solution and add 100-400 ul diluted primary antibody. Incubate overnight at 4 C.
5. Remove antibody solution and wash sections in wash buffer three times for 5 minutes each.
6. Add 100-400 ul HRP polymer conjugated secondary antibody. Incubate 30 minutes at room temperature.
7. Wash sections three times in wash buffer for 5 minutes each.
8. Add 100-400 ul DAB substrate to each section and monitor staining closely.
9. As soon as the sections develop, immerse slides in deionized water.
10. Counterstain sections in hematoxylin.
11. Wash sections in deionized water two times for 5 minutes each.
12. Dehydrate sections.
13. Mount coverslips.


Western Blot Protocol

1. Perform SDS-PAGE on samples to be analyzed, loading 10-25 ug of total protein per lane.
2. Transfer proteins to PVDF membrane according to the instructions provided by the manufacturer of the membrane and transfer apparatus.
3. Stain the membrane with Ponceau S (or similar product) to assess transfer success, and mark molecular weight standards where appropriate.
4. Rinse the blot TBS -0.05% Tween 20 (TBST).
5. Block the membrane in 5% Non-fat milk in TBST (blocking buffer) for at least 1 hour.
6. Wash the membrane in TBST three times for 10 minutes each.
7. Dilute primary antibody in blocking buffer and incubate overnight at 4C with gentle rocking.
8. Wash the membrane in TBST three times for 10 minutes each.
9. Incubate the membrane in diluted HRP conjugated secondary antibody in blocking buffer (as per manufacturer's instructions) for 1 hour at room temperature.
10. Wash the blot in TBST three times for 10 minutes each (this step can be repeated as required to reduce background).
11. Apply the detection reagent of choice in accordance with the manufacturers inst

Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.

FAQs

No product specific FAQs exist for this product.

View all FAQs for Antibodies